ABBEY VANDERMEID: Open Payments
NPI 1801131859 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,972 in 72 payments from 15 companies in 2025. Trend: 2023 $1,584 · 2024 $2,153 · 2025 $1,972
Food & beverage: $1,782Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $348 |
| ABBVIE INC. | 13 | $306 |
| Amgen Inc. | 10 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $193 |
| PFIZER INC. | 8 | $184 |
| UCB, Inc. | 6 | $125 |
| Organogenesis Inc. | 4 | $102 |
| LEO Pharma Inc. | 4 | $98 |
| Lilly USA, LLC | 4 | $92 |
| GENZYME CORPORATION | 2 | $87 |
Products named: TREMFYA, SKYRIZI, OTEZLA, DUPIXENT, CIBINQO, Bimzelx, ILUMYA, AFFINITY.
Industry payments across GA — which companies pay providers there.
